Seed9 July 2024

PolyModels Hub raises £1.1m seed funding from Marathon Venture Capital to expand its pharma development platform.

Marathon Venture Capital led the seed round to support team expansion and product development.

£1.1MSeed

PolyModels Hub is a biotech software company building a digital platform for biopharma process development. The firm combines advanced modelling and workflow management to help pharmaceutical teams design and manufacture medicines more efficiently.

PolyModels Hub has secured £1.1m in a seed funding round led by Marathon Venture Capital. The fresh capital will be directed towards team expansion and accelerating the development of the company software platform.

The London-based business provides ModelFlow, an integrated digital environment designed to help pharmaceutical researchers manage simulation tools and collaborate on drug development projects. The funding will allow the team to roll out advanced modelling features and scale operations to meet growing industry demand.

From the founder

"Developing a drug remains an expensive and time-consuming process. Unlike other industries, product development in pharmaceuticals relies heavily on numerous experiments with minimal knowledge transfer from past products, driven by the expertise and know-how of scientists. We have witnessed first-hand the inefficiencies of traditional drug development, as well as the growing desire and business need to transform this field. Our vision for PolyModels Hub is to revolutionise how scientists, digital teams, and senior stakeholders collaborate to accelerate development efforts and bring breakthrough therapies to market faster than ever. With today’s advanced technology, supportive business context, and favourable regulatory framework, we believe now is the perfect time to realise this vision."

Antonio Benedetti

Co-Founder and CEO at PolyModels Hub

Investor perspective

"The pharma industry is being revolutionised by modern technologies including AI, biotechnology, and robotics. Yet, pharma process development, which is a critical part of taking a drug product to market, is still driven by the empirical knowledge of scientists and relies on paper-based systems and manual processes. PolyModels Hub brings a rare mix of chemical and software engineering expertise to digitalise pharma process development and help pharma deliver breakthrough therapies faster to the growing and ageing population. We are excited to work together with the team towards bringing their vision forward"

Alex Alexakis

Partner, Marathon Venture Capital